Kidtrayze

Zinc chloride, potassium iodide, sodium selenite, copper chloride dihydrate, manganese chloride tetrahydrate, the active ingredient in Kidtrayze, is a trace element supplement presented as an unspecified strength intravenous solution for intravenous use. It is used to prevent or treat trace element deficiencies in patients requiring parenteral nutrition.

GNH USA supplies Kidtrayze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kidtrayze provides essential trace elements and is indicated for conditions related to trace element deficiency. - Trace element deficiency: restores adequate zinc, iodine, selenium, copper and manganese levels. - Parenteral nutrition support: contributes to overall nutritional balance in patients receiving intravenous feeding. - Post‑operative recovery: supports metabolic processes during healing when oral intake is limited.

Kidtrayze may be associated with adverse reactions during or after infusion.

Common Side Effects: - Infusion site irritation: redness or pain at the injection site. - Mild nausea: transient feeling of queasiness. - Transient metallic taste: brief metallic sensation in the mouth. - Headache: mild to moderate headache during infusion. - Low‑grade fever: temporary rise in body temperature. - Mild electrolyte shift: temporary changes in serum electrolytes.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Copper toxicity: signs include abdominal pain, liver dysfunction. - Zinc toxicity: nausea, vomiting, immune suppression. - Selenium overdose: respiratory distress, hair loss. - Severe electrolyte imbalance: cardiac arrhythmias. - Renal impairment: reduced kidney function following infusion.

Kidtrayze should be used with careful clinical monitoring. - Baseline trace element assessment: measure serum zinc, copper, selenium and iodine before initiating therapy. - Renal function monitoring: adjust use in patients with impaired kidney function. - Avoid concurrent high‑dose trace element supplements: risk of overload and toxicity. - Observe for hypersensitivity: discontinue infusion if signs of allergic reaction appear. - Use aseptic technique: ensure sterility of the IV line and solution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidtrayze may interact with certain medications and substances.

Major Interactions (Avoid): - High‑dose copper supplements: increase risk of copper toxicity. - High‑dose zinc supplements: may cause antagonistic absorption and imbalance. - Thyroid hormone therapy: excess iodine can affect thyroid function. - Chelating agents (e.g., EDTA): bind trace elements and reduce efficacy. - Renal dialysis: may remove administered trace elements, reducing therapeutic effect.

Moderate Interactions (Monitor Closely): - Tetracycline antibiotics: zinc can reduce antibiotic absorption (relevant for oral routes). - Anticoagulants: trace elements may influence coagulation parameters. - Diuretics: may alter electrolyte balance, requiring monitoring.